UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000021553 |
|---|---|
| Receipt number | R000024460 |
| Scientific Title | CA-GO therapy for eldery patients with 1st relapsed or primary refractory CD33-positive acute myelogenous leukemia. |
| Date of disclosure of the study information | 2016/03/21 |
| Last modified on | 2020/03/27 09:51:20 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2016/03/21 17:47:12 | ||
| 2 | Update | 2016/03/29 21:41:38 | Public title Acronym Acronym |
|
| 3 | Update | 2016/03/29 21:43:34 | Primary outcomes Primary outcomes |
|
| 4 | Update | 2016/11/03 20:16:26 | Name of primary person or sponsor Organization Organization1 Tel1 Email1 Institutions |
|
| 5 | Update | 2020/03/27 09:44:15 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Last name of contact person Last name of contact person Zip code Organization Organization Address Address Tel |
|
| 6 | Update | 2020/03/27 09:47:09 | URL releasing protocol URL related to results and publications Number of participants that the trial has enrolled Results Results Results date posted Baseline Characteristics Baseline Characteristics Participant flow Participant flow Adverse events Adverse events Outcome measures Outcome measures |
|
| 7 | Update | 2020/03/27 09:51:20 | Recruitment status Date of IRB |
